Long term use of AstraZeneca’s blood thinner Brilinta has been recommended as a cost-effective option in the UK for treating patients after a heart attack.

A Welsh stem cell company founded by a Nobel prize winner has signed a partnership deal with Daiichi Sankyo.

U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories’ novel coronary stent that dissolves after it is implanted. Abbott is seeking U.S. approval to sell the stent, called Absorb, as an alternative to metal stents currently used to prop open arteries cleared of […]

Novo Nordisk and AstraZeneca, two drugmakers whose financial outlooks disappointed investors last month, are both hoping for a boost in the coming weeks from results of two closely watched clinical trials.   AstraZeneca wants to prove its blood-thinner Brilinta can help stroke patients, in addition to those with heart problems, while Novo aims to showcase the […]

(Reuters Health) – After surviving a heart attack or severe blockage of blood flow to the heart, optimistic people are more likely to make healthy lifestyle changes and less likely to end up back in the hospital, a U.S. study suggests. Optimism was linked to an 8 percent lower risk of repeat hospitalizations in the […]

A restaurant industry trade group is suing New York City’s Board of Health to stop it from enforcing a new rule requiring many chain restaurants to post warnings on menu items that are high in sodium.   The National Restaurant Association said on Thursday the Board of Health unfairly burdened restaurant owners and usurped the […]

An experimental heart drug from GlaxoSmithKline failed to work as hoped in the first part of a large clinical trial, the company said on Tuesday, dealing a blow to its pipeline of new medicines.   Losmapimod was being assessed as a treatment to reduce the risk of further cardiovascular problems after heart attacks, but it […]

A new blood test might help doctors figure out faster whether someone’s having a heart attack. The test reliably told doctors which patients were not having heart attacks after only one blood sample, compared to the current method that requires several hours and multiple blood samples, researchers found. “The ultimate goal would be to have […]

Express Scripts Holding Co, the largest manager of prescription drug plans for U.S. employers and health plans, said it has reached deals to cover two costly new cholesterol drugs and expects to spend no more than $750 million on them next year. The injected drugs – Repatha from Amgen Inc and Praluent from partners Regeneron […]

A biotech company founded by a Nobel prize winner has won the go-ahead from European regulators to begin the application process for conditional marketing authorization of a stem cell-based regenerative heart treatment. Conditional approval, if granted, would allow Cardiff-based Cell Therapy to start selling its Heartcel product for regenerating damaged areas of heart while continuing […]